KL‐6 levels are significantly increased in IPF patients (1344 ± 140.4 U/ml) compared with both other‐ILD patients (850.7 ± 125.4 U/ml) and healthy controls (248.6 ± 7.406 U/ml) (Figure 1A). This evidence concerns the gene MUC1 and interstitial lung disease.